Company Analysis

Bionano Genomics, Inc. (BNGO)

Nasdaq: BNGO · Laboratory Analytical Instruments · San Diego, CA · filing with the SEC since 2007
Grade3.3
◀ Past 2.2● Present 3.4▶ Future 4.1
1 est.

Who owns Bionano Genomics, Inc.

As filed with the SEC
Holders of 5% or more
5
Ayrton Capital LLC holds 9.99% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G filed Nov 13, 2025 says.
Directors and officers
12
report now, of 26 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Ayrton Capital LLC
SCHEDULE 13G · filed Nov 13, 2025 · Common Stock, $0.0001 par value per share
9.99%
Orin Hirschman
SCHEDULE 13G · filed Oct 19, 2026 · Common Stock, $0.0001 par value per share
9.9%
CVI Investments, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Feb 17, 2026
9.9%
Lind Global Fund III LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Nov 14, 2025
9.35%
Lincoln Alternative Strategies LLC
SCHEDULE 13G · filed Sep 17, 2025 · Common Stock, par value $0.0001 per share
5.42%
Richard Abbe
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Shares, no par value · reported falling below 5%, from 4.99% in Nov 14, 2025
under 5%
Mitchell P. Kopin
SCHEDULE 13G · filed Sep 19, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
under 5%
What BNGO reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Purgien
A company bought · acquisition · owns, named in the 10-K filed Mar 23, 2026

2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 23, 2026.

Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
1821222326
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 40 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Luderer AlbertInterim Chief Executive0$002$0
SI Assistanton BNGO · research, not advice